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REKABENTUK KOMBINATORIAL BAGI ANALOG MAYA ASID 
SIALIK TERHADAP HEMAGGLUTININ DARIPADA INFLUENZA 
A DENGAN MENGGUNAKAN PENDEKATAN STRUKTUR DAN 
FRAGMEN 
 
Abstrak 
 
 
 Perencatan virus influenza A untuk menghindarkan daripada morbiditi dan 
mortaliti merupakan perkara utama yang diambil kira semasa epidemik dan sangat 
penting semasa pandemik. Terdapat dua jenis glikoprotein permukaan yang 
membentuk permukaan utama penentu antigenik virus influenza A iaitu 
hemagglutinin (HA) dan neuraminidase (NA). HA bertanggungjawab untuk 
perlekatan viral pada sel yang dijangkiti melalui pengikatan dengan moieti asid sialik 
(SA) permukaan. NA pula bertanggungjawab untuk menghidrolisis ikatan glikosidik 
yang menghubungkan SA dengan membran sel dan menyebabkan pemisahan viral. 
Kaedah rekabentuk dadah berasaskan struktur telah berjaya digunakan dalam mereka 
bentuk secara klinikal perencat NA iaitu Zenamivir dan Oseltamivir yang 
menghalang pemutusan virus progeni. Walau bagaimanapun, tiada perencat dengan 
berat molekul rendah yang telah direka berkesan untuk bertindak terhadap HA dan 
seterusnya mencegah pengikatan viral pada sel perumah. 
 
 Dalam kajian ini, kaedah pemodelan molekul telah digunakan untuk mereka 
bentuk pangkalan data analog maya SA dengan penggantian tunggal sama ada pada 
kedudukan C2, C5 atau C6 rangka SA. Molekul fragmen yang terdapat secara 
komersial telah digunakan sebagai calon pengganti. Dengan menggunakan 
pendekatan pendokkan molekul, fragmen molekul telah didok pada kantung ikatan 
HA di tapak pengikatan kristalografi C2, C5 dan C6 kumpulan berfungsi SA natural 
dan analognya yang lain. Kemudian, fragmen yang telah diorientasi digabungkan 
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secara automatik pada rangka SA dengan/atau tanpa bantuan molekul penghubung 
menggunakan algoritma empirikal yang dibangunkan secara dalaman. Oleh itu, tiga 
pangkalan data analog SA dengan penggantian fragmen tunggal pada C2, C5 dan C6 
telah berjaya dihasilkan. Ketiga-tiga pangkalan data kemudiannya didokkan pada 
keseluruhan tapak ikatan SA di kantung pengikat HA menggunakan kaedah 
pendokkan yang disahkan untuk menentukan ketepatan konformasi dan afiniti ikatan. 
Keputusan pendokkan menunjukkan afiniti analog yang dihasilkan adalah lebih 
tinggi (mencecah 30,000 kali ganda) daripada SA natural. Tenaga ikatan yang lebih 
baik menunjukkan tenaga ikatan daripada fragmen dan rangka SA kristal boleh 
digabungkan ke dalam analog yang dihasilkan.  
 
Dengan menggunakan terbitan C5 dan C6 analog SA yang menunjukkan 
afiniti tinggi dan penyimpangan dari kedudukan rangka kristal SA yang kecil, satu 
pangkalan data  analog kombinatorial SA telah dihasilkan  dengan mengesktrak 
kumpulan penukarganti C5 dan C6 dan kemudiannya menggabungkan mereka secara 
sistematik ke dalam rangka tunggal molekul SA. Peraturan Lima Lipinski telah 
diaplikasikan untuk membentuk hanya analog dengan pembolehdapatan oral. 
Keputusan pendokkan menunjukkan afiniti analog kombinatorial terhadap kantung 
HA adalah lebih tinggi berbanding analog penggantian tunggal dan affinitinya 
melebihi 100,000 kali ganda daripada SA natural memandangkan kebanyakkan 
analog SA yang direka bentuk boleh mengikat SA pada tapak ikatan HA dengan 
afiniti yang lebih tinggi berbanding SA asal, mereka mempunyai potensi untuk 
merencat virus influenza A daripada terikat kepada membran sel perumah dan 
seterusnya bertindak sebagai agen anti-flu. 
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COMBINATORIAL DESIGN OF VIRTUAL SIALIC ACID 
ANALOGUES AGAINST INFLUENZA A HEMAGGLUTININ 
USING STRUCTURE AND FRAGMENT BASED APPROACHES 
 
Abstract 
 
Inhibition of influenza A virus to avoid morbidity and mortality is of main 
concern during epidemics and of major concern during pandemics. Two types of 
surface glycoprotein form the main surface antigenic determinants of influenza A 
virus i.e. hemagglutinin (HA) and neuraminidase (NA). HA is responsible for viral 
attachment to the infected cell through surface-bound sialic acid (SA) moieties, while 
NA is responsible for hydrolysing the glycosidic bond that connects SA with the cell 
membrane resulting in viral detachment. Structure-based drug design approach has 
been successfully used in designing the clinically available NA inhibitors Zenamivir 
and Oseltamivir which restrict the progeny virus detachment. However, there is 
no effective low molecular weight inhibitor that has been developed to target HA and 
prevent the initial viral attachment to the host cell. 
 
 In this study molecular modeling techniques were used to design databases 
of virtual SA analogues by a single substitution at either of C2, C5 or C6 positions of 
SA scaffold. A commercially available molecular fragment was used for the 
substitution candidate. By using molecular docking approach, the molecular 
fragments were docked against the HA binding pocket at the crystallographic binding 
sites of C2-, C5- and C6-natural functional groups of SA and its analogues. Then, the 
oriented fragments were connected automatically to the SA scaffold with or without 
the incorporation of molecular linkers using in-house developed empirical 
algorithms. Thus, three databases of SA analogues with single substituted fragments 
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at positions C2, C5 or C6 were successfully generated. The three databases were then 
docked against the whole SA binding site using a validated docking tool to estimate 
the accurate binding conformations and affinities. Our docking results showed that 
the affinities of the generated analogues were higher (up to 30,000 fold) than the 
natural SA. The improvement in binding energies indicates that the favourable 
binding energies of the oriented fragments and the crystal SA scaffolds were 
additively merged within the generated analogues.  
 
Using the C5-derived and C6-derived SA analogues that showed higher 
affinities with little deviations from the crystal SA scaffold’s position, a database of 
combinatorial SA analogues was generated by extracting the C5- and C6-designed 
substitutions and combining them systematically on a single SA scaffold molecule. 
The Lipinski’s rule of five was applied to construct only the oral bioavailable 
analogues. The docking results showed that the affinities of combinatorial analogues 
were higher than the analogues of single substitution and exceed 100,000 fold the 
affinity of natural SA. As many of the designed SA analogues could bind the SA 
binding site of HA with higher affinity than the natural SA, they have the potential to 
inhibit influenza A virus from attachment to host cell membrane and consequently 
act as anti-flu agents. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Problem statement 
 
Influenza A virus is an enveloped negative strand RNA virus belongs to the 
Orthomyxoviridae family and responsible for the annual influenza epidemics and 
recurrent pandemics. There are many subtypes of influenza A classified by 
antigenicity of their corresponding surface glycoproteins i.e. hemagglutinin (HA) and 
neuraminidase (NA). Currently, 16 serotypes of HA and 9 serotypes of NA are 
available (Fouchier et al., 2005; Baker et al., 1987). HA glycoprotein is responsible 
for sticking the virus to the host cell before being engulfed by endocytosis and this 
attachment is mediated by surface-bound sialic acid (SA) moieties of the cell 
membrane (Skehel & Wiley, 2000), while NA is responsible for releasing the 
progeny viruses from the infected cell by hydrolysing O-glycosidic bond between the 
terminal SA which is bound to HA and the penultimate sugar moiety that connect SA 
to host cell membrane (Air & Laver, 1989). As functions of HA and NA oppose each 
other, a balanced effect is required for effective viral infection (Wagner et al., 2002). 
HA and NA are highly vulnerable to mutagenic changes by shift and/or drift in 
response to the pressure of host’s immune system (Lewis, 2006), that caused 
vaccination against influenza A virus is ineffective and pandemics are recurrent 
(Kilbourne, 1975).  
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SA (or 5-amino-3,5-dideoxy D-glycero-D-galacto nonurosonic acid) is a 
member of the natural SAs family and is the natural ligand for both of HA and NA 
(Varki & Varki, 2007; Schauer & Kamerling, 1997; Furuhata, 2004). SA is 
connected to the penultimate galactose moiety of the host cell membrane by two 
different modes. In the first mode, SA C2 is connected by α-O-glycosidic linkage to 
C3 of galactose (α(2,3)). This linkage predominates in the avian intestine. While in 
the second mode, the connection of SA to C6 of galactose gives the α(2,6) linkage 
which predominates in human respiratory tract. The binding between SA and HA is a 
simple bimolecular association. SA binds to the conserved amino acids mainly by 
bristling hydrogen bonds. No chemical reactions took place and no apparent 
conformational changes occurred at the binding site upon binding SA.  
 
Pyranose ring forms the scaffold of SA molecule, to which different 
functional groups are connected through carbon atoms C2, C4, C5, and C6. Changes 
in SA functional groups may confer changes in affinity toward HA as well. Several 
studies have been conducted to monitor the effect of modifying natural SA functional 
groups on the affinity toward HA to produce monovalent inhibitors, or incorporate 
several molecules of SA analogues of low affinity on large molecular weight carrier 
to produce polyvalent inhibitors (Matrosovich & Klenk, 2000). 
 
The HA of influenza A H3N2 (X-31) virus is of H3 serotype which is 
preferentially binds human type SA receptor (SA-α2,6-galactose) (Rogers & Paulson, 
1983). There is a theory of periodical recirculation of H3N2 in human population 
(Masurel & Marine, 1973). H3 bound to various SA analogues was exclusively 
studied by X-ray crystallography (Weis et al., 1988; Sauter et al., 1992a; Ha et al., 
3 
 
2003), NMR (Sauter et al., 1989, Sauter et al., 1992a; Machytka et al., 1993), 
alongside with inhibitory assays (Pritchett, 1987; Pritchett et al., 1987; Kelm et al., 
1992; Toogood et al., 1991). However, no effective monovalent agents have been 
developed yet which target the HA and inhibit viral attachment, even though HA has 
been long identified as a probable target for inhibitor design (Pritchett et al., 1987; 
Weis et al., 1988; Sauter et al., 1989; Sauter et al., 1992a; Machytka et al., 1993; 
Lentz, 1990).  
 
Molecular modelling techniques are developing fast, with some branches are 
matured enough and effectively participated in designing and screening drug 
candidates. With respect to HA, AutoDock3.05 has been used to reproduce crystal 
conformation of SA within HA primary binding site with estimated binding energy 
close to the observed value (Morris et al., 1998). The scope of this research is to 
design virtual databases of SA analogues of higher affinities toward the HA of 
influenza A H3N2 by substituting the natural SA functional groups with 
commercially available molecular fragments.  
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1.2 Influenza virus 
 
Influenza viruses belong to the Orthomyxoviridae family of RNA viruses 
which include influenza A, influenza B, influenza C, Thogoto (sometimes referred as 
influenza D), and Isa viruses (Cox et al., 2000). Influenza A can infect human, 
mammals, and birds (Webster et al., 1992)., while influenza B infects human and 
seals (Osterhaus et al., 2000) and influenza C infects human and pigs (Yuanji et al., 
1983). 
 
Influenza A is a major cause of morbidity and mortality in humans during 
annual epidemics and the recurrent pandemics. Influenza A mainly infects the 
epithelium of the upper and lower respiratory tracts and typically results in an abrupt 
onset of illness that usually includes high fever, coryza, cough, headache, prostration 
myalgia besides upper respiratory tract congestion and inflammation. These 
symptoms persist for 7 to 10 days while weakness and fatigue may extend for weeks. 
Pneumonia is a frequent manifestation of more severe infection. Influenza A 
infection is also a relatively common aetiology of laryngotracheitis (croup) in 
children and bronchiolitis. Myocarditis, encephalitis, and other extra-respiratory tract 
diseases are rarely occurred during the course of influenza infection. Viral infection 
is also associated with an increased incidence of subsequent otitis media, and 
influenza A pneumonia which may be complicated by subsequent infection with 
bacterial pathogens such as Staphylococcus aureus. Finally, influenza A infection is 
an important trigger of reactive airway disease in those with pre-existing asthma, and 
it may also promote allergic sensitization to environmental proteins (Lewis, 2006; 
Taubenberger & Morens, 2008). 
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Influenza A virus is an enveloped negative single-stranded RNA virus. It is a 
spherical to rod particle of 120 nm in diameter. Eight RNA segments are present 
inside the viral capsid and encode several proteins which include; HA and NA 
glycoproteins which are expressed on the viral surface, M2 protein which forms an 
ion channel that cross the viral lipid bilayer, and M1 protein which forms the internal 
matrix of the virus and used to encapsulate the genetic material while budding from 
the host cell membrane in the production of progeny viruses (Figure 1.1) 
(Bourmakina & García-Sastre, 2005; Lewis, 2006). 
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Figure 1.1: Influenza A virus with the external glycoproteins (HA and NA), trans-
membranal proteins (M2), internal protein matrix (M1) and RNA segments. 
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1.2.1 Hemagglutinin (HA) 
 
 
HA is a major antigenic determinant of influenza A virus, it is kind of lectins 
which are sugar-binding proteins (Lis & Sharon, 1998). Some protozoa, bacteria and 
viruses use SA-recognizing lectins to attach themselves to the cells of the host 
organism to initiate infection (Table 1.1). The influenza virus initiates infection by 
attachment to the host cell membrane followed by endocytosis and fusion with 
endosomal membranes. This attachment is mediated by interaction of terminal cell-
surface SA with viral surface glycoproteins (HA in influenza type A and B or 
hemagglutininesterase in influenza type C) (Paulson, 1985; Herrler et al., 1995).  
 
Each influenza virus contains about 500-1000 HA homotrimer (Ruigrok, et 
al., 1984 cited in Glick et al., 1991). HA monomer is synthesized as a single 
polypeptide (HA0) that is cleaved by host protease into two subunits (HA1 and HA2), 
in which HA1 is more variable antigenically compared to the HA2. Changes in this 
glycoprotein are responsible for uncontrolled recurrence of influenza epidemics 
(Webster & Laver 1975). Each HA monomer has two SA binding sites. The primary 
SA binding site is located at HA1 and responsible for viral sticking to the host cell, 
while the secondary binding site is located at the interface between HA1 and HA2 
(Figure 1.2) (Weis et al., 1988; Sauter et al., 1992a; Sauter et al., 1992b). The two 
binding sites are formed of well conserved amino acid residues through all subtypes 
of influenza A and strains of H3 serotype (Table 1.2) (Ward & Dopheide, 1981; 
Nobusawa et al., 1991). 
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During influenza A infection cycle, HA is first attached to the terminal SA 
residues spreaded on host cell surface. Subsequently, the virus is engulfed by the cell 
to form an endosome. The acidic environment of the endosomal compartment drives 
the necessary HA conformational changes to fuse the viral and the endosomal 
membranes which results in the intracellular release of the virion content (Skehel & 
Wiley, 2000) (Figure 1.3).  
 
Table 1.1: SA recognizing lectins in protozoa, bacteria and viruses (Varki et al., 
2008). 
 
Protozoa 
Parasite lectins: Merozoite erythrocyte-binding antigens (EBAs) (Plasmodium 
falciparum) 
Bacteria 
Bacterial adhesins: S-adhesin (Escherichia coli K99), SabA and SabB (Helicobacter 
pylori) 
Bacterial toxins: Cholera toxin (Vibrio cholerae), tetanus toxin (Clostridium tetani), 
botulinum toxin (Clostridium botulinum), pertussis toxin (Bordetella pertussis) 
Mycoplasma lectins: Mycoplasma pneumoniae hemagglutinin 
Viruses 
Hemagglutinins: Influenza A and B viruses, primate polyomaviruses, rotaviruses 
Hemagglutinin neuraminidases: Newcastle disease virus, Sendai virus, fowl plague 
virus 
Hemagglutinin esterases: Influenza C viruses, human and bovine coronaviruses 
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Figure 1.2: Influenza A HA homotrimer with the primary and secondary SA binding 
sites. 
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Host cell membrane 
 
 
Figure 1.3: The process of fusion between viral and endosomal membranes mediated 
by viral HA. a) Influenza A HA exposed on the viral surface (bottom) and pointed 
toward the host cell membrane (top). b) HA1 subunits displaced aside from locations 
over HA2, c) The loops between shorter and longer helices within each HA2 
subunits are extended. Red asterisk represents the exposed fusion peptides. d) 
Collapse of the extended intermediate loops to generate the post-fusion conformation. 
e) Magnified fusion point showing the N and C terminal for each of the three HA2 
subunits (Harrison, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
Viral membrane 
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1.2.2 Neuraminidase (NA) 
 
NA is the second major glycoprotein distributed on the influenza A viral 
surface. NA is arranged in tetramers and there are about 100-200 copies in each virus 
(Laver, 1973 cited in Glick et al., 1991; Schulze, 1973 cited in Glick et al., 1991). 
Each tetramer is composed of trans-membranal part, thin stalk, and globular head 
which has the ability to hydrolyse the O-glycosidic linkage that connects SA with the 
penultimate sugar moiety of the host cell membrane (Seto & Rott, 1966). During the 
course of influenza infection, NA could also function as scaventure to destroy the 
epithelial cells to facilitate the viral infection (Air & Laver, 1989). At the end of viral 
replication cycle, NA facilitates the release of the progeny viruses and prevents HA-
mediated viral aggregation (Palese et al., 1974). As the function of HA and NA 
oppose each other, a balanced effect is required for effective viral infection (Wagner 
et al., 2002). 
 
In each virus, NA exhibits specificity for terminal SA linkages similar to its 
relevant HA. Thus NA derived from avian influenza A virus can hydrolyze the α(2,3) 
glycosidic linkage between SA and penultimate galactose molecule, while NA 
derived from human influenza A virus can hydrolyse both  of α(2,3) and α(2,6) 
glycosidic linkages (see Section 1.4.3).  
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1.2.3 Influenza A virus subtypes 
 
There are many subtypes of Influenza A virus which can be classified 
according to the antigenicity of their corresponding HA and NA for example H1N1, 
H2N2, H3N2, and H5N1. Up to now there are about 16 serotypes of HA (Ron et al., 
2005) and 9 serotypes of NA (Baker et al., 1987). These numbers are vulnerable to 
increase as a consequence of antigenic shift and drift (Lewis, 2006). All the available 
HA serotypes besides their host ranges are listed in Table 1.3. 
 
 
 
 
 
 
Table 1.3: The available HA serotypes and their host ranges. 
 
HA serotype Host range Avian Human Equine Swine 
H1 X X  X 
H2 X X  X 
H3 X X X X 
H4 X    
H5 X    
H6 X    
H7 X  X  
H8 X    
H9 X   X 
H10 X    
H11 X    
H12 X    
H13 X    
H14 X    
H15 X    
H16 X    
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1.3 Sialic Acids (SAs) 
 
SAs is a name given to a group of more than 50 different analogues of the 
parent compound neuraminic acid (Neu) (5-amino-3,5-dideoxy-D-glycero-D-
galacto-non-2-ulopyranosonic acid) (Schauer, 2004). They are electronegatively 
charged acidic monosaccharides which participate in the structural diversity of 
complex carbohydrates that constitute the major part of proteins, cell membranes 
lipids and secreted macromolecules (Varki et al., 2008). 
 
 
 
1.3.1 Chemistry of SAs 
 
SAs are naturally occurring deoxy nononic acids of acetylated, sulphated, 
methylated, and lactylated derivatives comprising a large diverse family of 
compounds. Such diversity characterizes SA among other sugars (Angata & Varki, 
2002). Certain rules are followed in the nomenclature of SA derivatives (Blix et al., 
1957; Reuter & Schauer, 1988). Neu5Ac, Neu5Gc, KDN, and Neu are the four main 
SA molecules (Figure 1.4) from which other analogues are derived by carrying one 
or more additional substitutions at the hydroxyl groups on C-4, C-7, C-8, and C-9 
(Figure 1.5). For more information please see Schauer (1982) or Schauer and 
Kamerling (1997). 
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Neu5Ac: R=NHAc 
Neu5Gc: R=NHCOCH2OH 
KDN: R=OH 
Neu: R=H 
 
Figure 1.4: Different substitutions on C5 give the four main SAs molecules. 
 
 
 
 
R1 = H (on dissociation at physiological pH, gives the negative charge of SA); can form 
lactones with hydroxyl groups on the same molecule or on other glycans; can form lactams 
with a free amino group at C-5; or tauryl group. 
R2 = H; alpha linkage to Gal(3/4/6), GalNAc(6), GlcNAc(4/6), SA (8/9), or 5-O-Neu5Gc; 
oxygen linked to C-7 in 2,7-anhydro molecule; anomeric hydroxyl eliminated in Neu2en5Ac 
(double bond to C-3).  
R4 = -H; -acetyl; anhydro to C-8; Fu; Gal.  
R5 = Amino; N-acetyl; N-glycolyl; hydroxyl; N-acetimidoyl; N-glycolyl-O-acetyl; N-glycolyl-O-
methyl; N-glycolyl-O-2-Neu5Gc.  
R7 = -H; -acetyl; anhydro to C-2; substituted by amino and N-acetyl in Leg.  
R8 = -H, -acetyl, anhydro to C-4, -methyl, -sulfate, SA, Glc. 
R9 = -H, -acetyl, -lactyl, -phosphate, -sulphate, SA, OH substituted by H in Leg. 
 
Figure 1.5: Diversity in the SAs. The nine-carbon backbone common to all known 
SA is shown. The possible variations at the carbon positions are indicated. Glc stands 
for Glucose, Gal; Galactose, GlcNAc; Glucose amine, GalNAc; Galactose amine, Fu; 
Fucose, and Leg for legionaminic acid (Varki et al., 2008). 
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1.3.2 Biological roles of SAs 
 
The cell-surface of both eukaryotic and prokaryotic organisms contains 
glycocongugates which aid in cellular communications and adhesions. SAs have dual 
roles in the human body by masking the recognition sites against autoimmune 
response and in being the binding sites for various pathogens (Kelm & Schauer, 
1997). 
 
1. SAs positioning at the outer surface of the cell membrane shields the cell 
from infective organisms and autoimmune attack. Removing SAs regarded as 
mechanism for infectivity of various pathogens such as Vibrio cholerae 
(Taylor, 1996). In addition, removing surface SAs predispose the cell to the 
humoral immunity, a mechanism used for removing thrombocytes from the 
circulation (Kluge et al., 1992). Therefore, the malignant cells are protected 
from being attacked by the immune system by over expressing surface SA 
(Schauer, 2004). 
2. SAs on host cells act as anchors for adhesion and subsequent infection by 
various pathogens. Plasmodium falciparum use SAs on the erythrocyte 
surface as receptors for invasion (DeLuca et al., 1996). Accordingly, studies 
have been conducted to examine the ability of SAs in blocking the binding 
site on merozoits which could suppress the infectivity of malaria (Vanderberg 
et al., 1985). SAs associated with the host cell contribute to invasion by 
Trypanosoma cruzi (Schenkman et al., 1993). Influenza virus A and B are 
attached to the host cell surface through SA moieties using HA glycoprotein 
while the paramyxoviruses (parainfluenza viruses) have HA-NA 
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glycoproteins system that enables the virus to attach the host cell through SA 
followed by membranes fusion by fusion glycoprotein (Colman et al., 1993). 
 
Due to their electronegativity, SAs also participate in transformation of 
positively charged pharmaceuticals and in mutual repulsion between erythrocytes in 
the blood stream (Kelm & Schauer, 1997; Schauer & Kamerling, 1997). 
 
 
1.3.3 SA is the natural ligand of influenza A HA 
 
The C5-N-acetyl substituted neuraminic acid (Neu5Ac) is the natural ligand 
for HA in all subtypes of influenza A. The molecular structure of SA is composed of 
central pyranose ring from which different functional groups are protruded. The 
functional groups include C2-axial carboxylate, C2-equatorial hydroxyl, C4-
equatorial hydroxyl, C5-equatorial N-acetyl (acetamido) group, and C6-equatorial 
glycerol (Figure 1.6). Methyl-α-Neu5Ac is the simplest SA analogue that has been 
studied crystallographically in complex with HA. 
 
 
 
 
 
 
Figure 1.6: The molecular structures of natural SA (R=H) and methyl-α-Neu5Ac 
(R=CH3). 
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1.4 HA-SA molecular interaction 
 
 
1.4.1 The binding site of SA at HA1 (primary SA binding site). 
 
The primary SA binding sites are located at HA1 subunits of HA and formed 
from well conserved amino acid residues. The phenolic hydroxyl of Tyr98 and the 
aromatic ring of Trp153 form the bottom of the binding site. There are three 
polypeptide loops forming the boundaries of this binding site; i.e. loop 130 (includes 
Gly135, Ser136, Asn137, and Ala138), loop 220 (includes Arg224, Gly225, Leu226, 
Ser227, and Ser228), and α-helix 190 which form the rear of the site from which the 
side chains of Glu190 and Leu194 are projected down toward the binding site 
(Figure 1.7) 
  
 
1.4.2 The interaction between SA and HA1 binding site. 
 
The interactions between SA and HA1 binding site follow simple bimolecular 
interaction (Sauter et al., 1989). At the binding site, one face of the SA’s pyranose 
ring faces the bottom of the site while the other face is exposed to the solution. The 
axial carboxylate, acetamido nitrogen, and two of glycerol hydroxyls are interacted 
by hydrogen bonds with conserved amino acid residues (Figure 1.7). 
 
C2-carboxylate forms the most stable and important interactions with HA1 
binding site where one of the carboyxlate oxygens accepts hydrogen bond from the 
side-chain of Ser136 while the other oxygen accepts hydrogen bond from Asn137 
main chain amide. The C4-hydroxyl group projects outside the binding site, and 
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appears not to participate in binding due to its equatorial epimerization. With respect 
to C5-acetamido nitrogen, a hydrogen bond is donated to the main chain carbonyl of 
Gly135, while the terminal methyl group is in van der Waals contact with six-
membered ring of Trp153. The C7-hydroxyl group and the C5-acetamido carbonyl 
form intra-molecular hydrogen bond and both are in van der Waals contacts with 
Leu194. The C8-hydroxyl group forms hydrogen bond with the side chain of Tyr98 
while C9-hydroxyl group establishes hydrogen bonds with the side chains of Tyr98, 
His183, Glu190, and Ser228 (Weis et al., 1988; Sauter et al., 1989; Sauter et al., 
1992a). 
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Figure 1.7: Natural SA binding site at HA1 of influenza A virus H3N2 (X-31). 
Dotted lines indicate hydrogen bonds between SA and HA, while dashed lines show 
potential hydrogen bonds within the protein (Sauter et al., 1989). 
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1.4.3 Specificity of the interaction between HA and SA. 
 
 
1.4.3.1 Specificity of HA1 toward SA follows the type of SA-O-glycosidic 
linkage. 
 
The type of glycosidic linkage that connects SA moiety to the penultimate 
galactose residue at terminal cell-membranal carbohydrates determines the affinity 
whether toward human or avian influenza HA, and vice versa (Rogers & Paulson, 
1983).  Accordingly, Neu5Ac-α(2,3)-Gal is recognized by avian viruses while 
Neu5Ac-α(2,6)-Gal is recognized by human  viruses (Figure 1.8). 
 
 
 
 
 
 
Figure 1.8: Different HAs have different specificities in recognizing these linkages. 
The HA derived from wild type A/Hong Kong/68, X-31 H3N2 influenza A virus 
with Leu226 (Human virus) has high affinity to Neu5Ac-α(2,6)-Gal while the 
Leu226Gln mutant (Avian virus) favours Neu5Ac-α(2,3)-Gal linkage. 
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The HA specificity governs the viral host range. The humans viruses 
recognize α(2,6) linkage, and those from avians and equines recognize α(2,3) 
linkages, while swine viruses recognize both types of linkages (Rogers & D’Souza, 
1989; Connor et al., 1994; Matrosovich et al., 1997; Gambaryan et al., 1997; Ito & 
Kawaoka, 2000). Accordingly, the viral inter-species transferences are limited. 
Humans pandemics occur when the HA specificity of virus from other species 
change specificity from α(2,3) to α(2,6) for which humans have no immunity. The 
worldwide pandemics in 1918, 1957, and 1968 (WHO, 1980) are caused by H1, H2, 
and H3 viruses, respectively, when the HA specificity have been changed (Ha et al., 
2001; Rogers & D’Souza, 1989; Matrosovich et al., 1997). Accordingly, the reason 
why H5 avian influenza outbreak in 1997 failed to develop pandemic was due to the 
inappropriate α(2,3) specificity. 
 
H5N1 virus could infect cells in the human’s lower respiratory tract where 
α(2,3) terminal SA dominates, this limitation is responsible for inefficient human to 
human transmission in 1997 (Shinya et al., 2006). Therefore, for the virus to be 
disseminated it must infect the upper respiratory tracts where it can be shed out by 
sneezing and coughing. To infect the cells of upper respiratory tracts, the virus 
should have the ability to bind α(2,6) terminal SAs (Baum & Paulson, 1990; 
Couceiro et al., 1993). Because both of α(2,3) and α(2,6) linkages are present in the 
human respiratory tracts  (Shinya et al., 2006; Couceiro et al., 1993), while α(2,3) 
linkages are present in the avian intestine (Naeve et al., 1984), the influenza A 
infection in human, equines, and swines is respiratory, while it is enteric in avians. 
Interestingly, pigs acquire both types of linkages in their respiratory tract thus can be 
infected by both of avian and human viruses (Hinshaw et al., 1981; (Kida et al., 
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1994). Accordingly, pigs serve as “mixing –vessels” providing the molecular basis of 
developing human-avian influenza A virus reassortants, similar to those responsible 
for 1957 and 1968 pandemics (Ito et al., 1998) (Figure 1.9).  
 
 
 
Figure 1.9: Avian influenza A virus is reassorted in pigs to become human infective 
(Alberto Cuadra, 200?)  
 
 
 
In Europe during 1979 H1N1 avian and H3N2 human viruses co-circulated in 
pigs and eventually reassorted to this host (Castrucci et al., 1993) generating a new 
type of viruses with HA and NA harbor both avian and human genotypic 
characteristics capable of infecting humans (Claas et al., 1994). Viruses isolated 
between 1979 and 1984 were capable of recognizing α(2,3) and α(2,6) linkages, 
while those isolated after 1985 can recognize only α(2,6) (i.e. human specific). 
Although humans and nonhuman primates can be experimentally infected with avian 
viruses, the limited viral replication in these hosts has led to the conclusion that avian 
influenza viruses are not directly transmitted to humans in nature (Horimoto & 
Kawaoka, 2001). 
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1.4.3.2 Determinants of HA1 specificity 
 
Sequence analysis of HA isolated from various avian and human strains 
revealed that some amino acid substitutions at locations close and far away from the 
HA1 binding site can affect HA specificity toward the type of SA linkage. Similar to 
H2 serotypes, H3 serotypes viruses undergo Gln226Leu and Gly228Ser mutations 
converting the avian specific HA to human specific one (preferring α(2,6) linkages) 
(Rogers & Paulson, 1983; Rogers et al., 1983; Sauter et al., 1989; Pritchett et al., 
1987; Nobusawa et al., 1991; Naeve et al., 1994;; Connor et al., 1994; Vines et al., 
1998). These mutations make the SA binding site at HA1 little opened and allow the 
residues within it to rearrange (Ha et al., 2003). Narrower binding site is observed for 
H5 serotype of 1997 H5N1 avian virus which has Gln226 and Gly228 and has high 
affinity for α(2,3) linkages and low affinity for α(2,6) linkages (Figure 1.10). The 
low affinity to α(2,6) linkages was responsible for H5N1 infectivity to humans in 
1997 (Ha et al., 2001). In H1 serotype the Gln226 and Gly228 were maintained 
while Glu190Asp mutation converts the virus from avian to human specific 
(Matrosovich et al., 2000).  
 
